EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Two-year outcomes of endoscopic transpapillary gallbladder stenting versus EUS-guided transmural gallbladder drainage in high-surgical risk patients with acute calculous cholecystitis: a randomized trial

J. Chaikajornwat, W. Ridtitid, P. Piyachaturawat, P. Vongwattanakit, S. Kulpatcharapong, P. Angsuwatcharakon, P. Mekaroonkamol, P. Kongkam, R. Rerknimitr

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S88

DOI: 10.1055/s-0044-1782880 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von J. Chaikajornwat und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Endoscopic transpapillary gallbladder stenting (ETGS) and endoscopic ultrasound-guided transmural stenting (EUGS) can be performed as an alternative gallbladder drainage in high-surgical risk patients with acute calculous cholecystitis (AC). However, the durability of these two endoscopic treatments has not been compared.

Methods

During 2021-2023, high-surgical risk patients with AC (Charlson Comorbidity Index≥6) were randomized into group A (received ETGS) and group B (received EUGS). A 7-Fr/15-cm double-pigtail plastic stent (DPS) was used for ETGS. A 10 or 15 or 16-mm lumen-apposing metal stent (LAMS) or a 10x60 mm fully covered self-expandable metal stent with a 7-Fr/5-cm DPS for metallic stent anchoring (FCSEMS-DPS) were used for EUGS.

Results

A total of 55 eligible patients were randomized into group A (n=29) vs group B (n=26). Group A had a significantly lower technical success rate (TSR) than group B [24/29 (82.8%) vs. 26/26 (100%); p=0.03] with similar clinical success rate (CSR) [24/24 (100%) vs. 26/26 (100%)]. ETGS was not achieved in 5 patients due to an acute angle of the cystic duct (n=3) and cystic duct stone obstructing a guidewire traversing into the gallbladder (n=2). Of 5 patients with ETGS failure, two patients continued antibiotic treatment, 3 patients achieved subsequent EUGS. Procedure-related adverse events (PAE) rates did not differ between groups A and B including mild pancreatitis (3.4% vs. 0%; p=0.34), mild abdominal pain (6.9% vs. 15.4%; p=0.31), post-procedural bleeding (0% vs. 3.8%; p=0.29) and early stent migration (0% vs. 3.8%; p=0.29). In group A, 3 patients developed recurrence after 9 months (day 280, 285, and 436) due to stent occlusion and had ETGS stent replacement. In group B, 1 patient had FCSEMS-DPS migration seen on routine plain film at 2 weeks and had early recurrence at day 71 with subsequent LAMS replacement. Death occurred in 8 (27.6%) and 10 (38.5%) patients in groups A and B with a median time to death of 61.5 (range 8–896) and 87 (range 8–432) days, respectively, and was unrelated to gallstone. On an intention-to-treat basis, at 1 year and during 1-2 years, the rate of recurrent AC in those who survived did not differ between groups A and B [9.1% (2/22) vs. 5.6% (1/18); p=0.67 and 5% (1/20) vs 0% (0/16); p=0.36, respectively]. Kaplan-Meier analysis revealed a comparable overall rate of recurrence between the two groups (p=0.44) during a median follow-up of 373.5 (range 8-1021) days.

Conclusions

In high-surgical risk patients with AC, EUGS provided a significantly higher TSR than ETGS, with comparable CSR and PAEs. During a 2-year follow-up, the rates of recurrent AC in the ETGS and EUGS groups were comparable, with stent occlusion accounting for the major cause of recurrence in the ETGS group after 9 months. In the EUGS group, LAMS is preferred to prevent early stent migration. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Chaikajornwat, J., Ridtitid, W., Piyachaturawat, P., Vongwattanakit, P., Kulpatcharapong, S., Angsuwatcharakon, P., Mekaroonkamol, P., Kongkam, P., & Rerknimitr, R. (2024). Two-year outcomes of endoscopic transpapillary gallbladder stenting versus EUS-guided transmural gallbladder drainage in high-surgical risk patients with acute calculous cholecystitis: a randomized trial. Endoscopy, 56(S 02 S 02), S88. https://doi.org/10.1055/s-0044-1782880

Vancouver

Chaikajornwat J, Ridtitid W, Piyachaturawat P, Vongwattanakit P, Kulpatcharapong S, Angsuwatcharakon P, et al. Two-year outcomes of endoscopic transpapillary gallbladder stenting versus EUS-guided transmural gallbladder drainage in high-surgical risk patients with acute calculous cholecystitis: a randomized trial. Endoscopy. 2024;56(S 02 S 02):S88. doi:10.1055/s-0044-1782880

BibTeX
@article{Chaikajornwat2024,
  author = {Chaikajornwat, J. and Ridtitid, W. and Piyachaturawat, P. and Vongwattanakit, P. and Kulpatcharapong, S. and Angsuwatcharakon, P. and Mekaroonkamol, P. and Kongkam, P. and Rerknimitr, R.},
  title = {Two-year outcomes of endoscopic transpapillary gallbladder stenting versus EUS-guided transmural gallbladder drainage in high-surgical risk patients with acute calculous cholecystitis: a randomized trial},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S88},
  doi = {10.1055/s-0044-1782880}
}
Kostenlos starten →